The Novel Conjugates Summit is dedicated to advancing next-generation conjugate therapeutics, including ADCs, by focusing on innovative drug delivery, linker technology, and optimized therapeutic targeting. It brings together experts from biopharma, biotech, and academia to share insights and foster collaboration.

This J.P. Morgan healthcare conference is one of the largest and most informative healthcare investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.

Read more about this event on the conference website.